Abstract
Comparison between the Originator and Me-too Drugs of First- Generation EGFR-TKI in EGFR-Mutant NSCLC Patients: A Retrospective Cohort Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have